ReferIndia News Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

ReferIndia News

Want to grow your business digitally?

Let us help you get there—fast, smart, and effective.

Contact Now
News Image

Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar

Published on: May 1, 2026, 3:16 p.m. | Source: NDTV Profit

Available in 100 mg and 400 mg formulations, the originator product Avastin is marketed by Roche/Genentech, filing added.

Checkout more news
Ad Banner

Loans & Investments—All with Kunjesh

Business, Home, Mortgage, Personal Loans + Expert Investment Banking. Trusted since 2001. Quick approvals.

Get Started
ReferIndia News contact